USFDA revokes authorization of COVID antibody drugs of GSK, Lilly and 2 others Ruchika Sharma24 Dec 2024 12:30 PM ISTThe US Food and Drug Administration (USFDA) has revoked the emergency use authorisation for four Covid-19 antibody-based drugs from pharma...
Former Pfizer employee convicted of insider trading on COVID drug Paxlovid trial Ruchika Sharma22 Jan 2024 10:11 AM ISTA former employee of Pfizer Inc was convicted of insider trading on Thursday for buying stock options in November 2021 just before Pfizer announced...
High-doses of Covid medicines not effective in India than Europe Preksha garg2 Dec 2023 9:00 AM ISTAccording to a new study published in The Lancet Regional Health - Southeast Asia journal higher doses of the COVID-19 drug, dexamethasone, may have...
Health Bulletin 23/October/2023 Roshni Dhar23 Oct 2023 5:41 PM ISTHere are the top health stories for the day:Procuring Rs 650 Remdesivir at Rs 1568 during pandemic: FIR against pharma company Mylan for alleged Rs 6...
Medical Bulletin 04/October/2023 Isra Zaman4 Oct 2023 3:00 PM ISTHere are the top medical news of the day:WHO Recommends new Malaria Vaccine for children which is cost-effective and efficientIn a significant...
Merck, Ridgeback Biotherapeutics withdraw COVID pill Molnupiravir application in EU Ruchika Sharma30 Jun 2023 10:00 AM ISTMerck and Co and partner Ridgeback Biotherapeutics said on Tuesday they had withdrawn their COVID-19 pill application in the European Union,...
EMA panel grants positive opinion for Remdesivir use in COVID patients with severe renal impairment, including those on dialysis: Gilead Sciences Ruchika Sharma28 May 2023 12:00 PM ISTFoster City: Gilead Sciences, Inc. has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency...
USFDA nod to Pfizer Paxlovid for adult patients at high risk of progression to severe COVID 19 Ruchika Sharma26 May 2023 1:30 PM ISTPAXLOVID is a SARS-CoV-2 main protease (Mpro) inhibitor (also known as SARS-CoV-2 3CL protease inhibitor) therapy.
CSIR-IICT, 101 Therapeutics collaborate for COVID drug trials Ruchika Sharma8 May 2023 12:40 PM ISTThe agreement will be for 3 years tenure and on successful completion of the clinical trials, this drug would prove to be highly appropriate and...
SC dismisses plea seeking CBI probe against 10 pharma cos for selling Remdesivir, Favipiravir without valid license MD Bureau11 April 2023 3:30 PM ISTNew Delhi: The Supreme Court on Monday dismissed a plea alleging use of drugs Remdesivir and Favipiravir, without approval, for treatment of Covid-19...
EU drug regulator advices against market nod for Merck COVID pill Lagevrio for adults Ruchika Sharma26 Feb 2023 3:45 PM ISTUS: The European Union's drug regulator said on Friday its Committee for Medicinal Products for Human Use has advised against market authorisation of...
USFDA removes COVID test requirements for Merck, Pfizer pills Ruchika Sharma2 Feb 2023 12:15 PM ISTThe health regulator said individuals with recent known exposure with signs and symptoms may be diagnosed by their healthcare providers with COVID...
